Plus therapeutics expands collaboration with piramal pharma solutions to meet increase in investigational drug demand for ongoing and planned clinical trials

New supply agreement includes additional lots of intermediate drug product to support the manufacture of the rhenium (186re) obisbemeda radiotherapeutic

PSTV Ratings Summary

PSTV Quant Ranking